As of 2024-12-12, the Fair Value of BioMark Diagnostics Inc (BUX.CN) is -0.09 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.23 CAD, the upside of BioMark Diagnostics Inc is -139.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 5Y Avg | |
| Net income | -1.22 | -1.09 | -1.45 | -1.84 | -1.43 | -1.41 |
| YoY growth | -122.74% | 9.96% | -32.87% | -26.71% | 22.52% | -29.97% |
| Market Cap (mil) | 20.45 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -29.97% |
| TTM earnings | -1.63 |